• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

33
12
7
6
6

COUNTRY

12
2
2
1
1

CATEGORIES

  • 44
  • 20
  • 16
  • 14
  • 10
  • 9
  • 9
  • 7
  • 7
  • 5
  • 5
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

40
66
71
117

PUBLISHED

7
12
24
117

PRODUCT TYPE

57
32
25
2
1

Search "Clinical Management of Ovarian Cancer" returned 117 results.

Oncology Intelligence: A Comprehensive Report for Decision Making Oncology Intelligence: A Comprehensive Report for Decision Making - Product Thumbnail Image

Oncology Intelligence: A Comprehensive Report for Decision Making

Oncology Intelligence Report 2013 provides complete landscape on cancer drug development, by bringing more authentic data under evaluation and is designed in a manner to keep knowledge instant, clear...

January 2013

Oncology Drug Report - 2014

Report for the first time identifies and profiles 931 Active Cancer Drug Development companies from 33 countries worldwide, developing 2237 cancer-targeting drugs It evaluates 19 major cancer indications...

May 2014
FROM
Personalized Medicine - Scientific and Commercial Aspects Personalized Medicine - Scientific and Commercial Aspects - Product Thumbnail Image

Personalized Medicine - Scientific and Commercial Aspects

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her...

August 2015
FROM
Biomarkers - Technologies, Markets and Companies Biomarkers - Technologies, Markets and Companies - Product Thumbnail Image

Biomarkers - Technologies, Markets and Companies

This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological...

August 2015
FROM
Drug Delivery in Cancer - Technologies, Markets and Companies Drug Delivery in Cancer - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Cancer - Technologies, Markets and Companies

Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery...

August 2015
FROM

Clinical Trial Recruitment in Orphan Diseases - Patient Numbers in Ovarian Cancer Trials Exceed Other Orphan Diseases in Oncology

GBI Research, the leading business intelligence provider, has released its latest research, “Clinical Trial Recruitment in Orphan Diseases - Patient Numbers in Ovarian Cancer Trials Exceed Other Orphan...

November 2011
FROM

Current Approaches to Endometrial Cancer

As the symptom of atypical genital bleeding and discharge appears early in the clinical course, many women with endometrial cancer have early-stage disease at diagnosis. This leads to general recognition...

November 2014

The Top 70 Western European Oncology Contract Research Organisations

It is estimated that clinical development expenditures outsourced by pharmaceutical, medical device and biotechnology companies worldwide in 2012 was approximately Euro 20 6 billion With greatly developed...

July 2013
FROM

Oncology Therapeutics Market to 2017 - High Unmet Need in the Management and Treatment of Metastatic Cancers to Drive Drug Development

GBI Research, the leading business intelligence provider, has released its latest research, “Oncology Therapeutics Market to 2017 - High Unmet Need in the Management and Treatment of Metastatic Cancers...

December 2011
FROM

Novel cancer-related biomarkers Volume 2

Aims and Scope Various KLK proteins and their encoding genes have attracted increased attention among scientists and clinicians worldwide since they represent very interesting and functionally distinct...

December 2012
FROM

Soricimed Biopharma Inc. - Product Pipeline Analysis, 2014 Update

Summary Soricimed Biopharma Inc. (Soricimed), formerly BioProspecting NB Inc. is a drug development company. The company carries out the development and commercialization of therapeutic and diagnostic...

June 2014
FROM
Gene Therapy - Technologies, Markets and Companies Gene Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Gene Therapy - Technologies, Markets and Companies

Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes...

August 2015
FROM
Molecular Diagnostics - Technologies, Markets and Companies Molecular Diagnostics - Technologies, Markets and Companies - Product Thumbnail Image

Molecular Diagnostics - Technologies, Markets and Companies

This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological...

August 2015
FROM

Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2014

Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis....

July 2014
FROM

Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends and Pipeline Analysis)

“GLOBAL & USA CANCER BIOMARKER MARKET to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-development, Business Strategies, Industry Trends, and Pipeline...

May 2014
FROM
DNA Sequencing - Technologies, Markets and Companies DNA Sequencing - Technologies, Markets and Companies - Product Thumbnail Image

DNA Sequencing - Technologies, Markets and Companies

This report briefly reviews basics of human genome variations, development of sequencing technologies, and their applications. Current large and small sequencers are described as well as companies developing...

August 2015
FROM

The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives

The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular...

May 2013
FROM

Neogenix Oncology, Inc. - Product Pipeline Analysis, 2014 Update

Summary Neogenix Oncology, Inc. (NOI) is a clinical stage biotechnology company. The company develops therapeutic and diagnostic products for the early detection and treatment of cancer. Its antibody...

July 2014
FROM
Clinical Laboratory Services - Global Strategic Business Report Clinical Laboratory Services - Global Strategic Business Report - Product Thumbnail Image

Clinical Laboratory Services - Global Strategic Business Report

This report analyzes the worldwide markets for Clinical Laboratory Services in US$ Million by the following Product Segments: Hospital-Based Laboratories, and Others The report provides separate comprehensive...

January 2014
FROM

Ovarian Cancer Drug Pipeline Update 2015

With nearly 60,000 cases of ovarian cancer being diagnosed in the seven major markets each year, this cancer type is by no means small and therefore it remains an important secondary indication for...

June 2015
FROM
Loading Indicator

Our Clients

Abbott Laboratories Ltd. Ford Motor Company Honeywell International, Inc. Nike, Inc. Deloitte LLP. IMAX Corporation